I

Imophoron Ltd

14 employees

Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2017

Funding rounds raised

Total raised

$5.4M

from 1 investors over 1 rounds

I

Imophoron Ltd raised $5.4M on October 7, 2021

Investors: Octopus Ventures

FAQ